IMRT 2017

First page Previous page 97 Next page Last page

NEOADJUVANT

• 3-year estimated OS 95.4%

• 3-year estimated DFS 85.9%

• No local relapse was found

• 10 patients (13.8%) developed distant metastases

Made with FlippingBook flipbook maker